Breaking News

argenx NV ADR (ARGX)

Symbol	Exchange	Currency
ARGX	NASDAQ	USD	Real-time
ARGXb	BATS Europe	EUR	Delayed
0QW0	London	EUR	Real-time
1AE	Frankfurt	EUR	Delayed
ARGX	Brussels	EUR	Real-time
ARGX	Vienna	EUR	Real-time

Add to/Remove from a Portfolio Add to Watchlist

601.82 -6.14 -1.01%

03:32:26 - Real-time Cboe. Currency in USD

Type: Equity

Market: United States

Volume: 118,645
Bid/Ask: 0.00 / 0.00
Day's Range: 597.51 - 612.98

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

argenx NV ADR Company Profile

Get an in-depth profile of argenx NV ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

1599

Equity Type

ADR

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren’s disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

Contact Information

Address Laarderhoogtweg 25
Amsterdam, 1101 EB
Netherlands

Phone 31 10 703 8441

Fax -

Web argenx.com

Top Executives

Name	Age	Since	Title
David L. Lacey	71	2012	Member of Board Advisors
Pamela M. Klein	62	2016	Independent Non-Executive Director
J. Donald deBethizy	73	2015	Independent Vice-Chairman of the Board
Ana Cespedes	50	2022	Independent Non-Executive Director
Brian L. Kotzin	74	2024	Non-Executive Director
Hans de Haard	65	2008	Member of Board Advisors
Anthony A. Rosenberg	72	2017	Independent Non-Executive Director
Peter K. M. Verhaeghe	67	2008	Independent Chairman of the Board
Wim Parys	65	2019	Member of Board Advisors
Robert Keith Woods	57	2018	Member of Board Advisors
Steve Edward Krognes	57	2023	Independent Non-Executive Director
Timothy Van Hauwermeiren	53	2008	Co-Founder, CEO & Executive Director
James M. Daly	63	2018	Independent Non-Executive Director
Camilla Sylvest	53	2022	Independent Non-Executive Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Philippines's comment guidelines and agree to the terms described.

I Agree

ARGX Comments

Write your thoughts about argenx NV ADR

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d62-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d62-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d62-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

PSEi Composite	6,159.85	-32.17	-0.52%
Nikkei 225	37,780.54	+172.05	+0.46%
Shanghai	3,369.98	-0.05	0.00%
US 500	5,769.2	+1.6	+0.03%
US Tech 100	20,250.1	+69.6	+0.35%
DAX	23,104.76	+252.10	+1.10%
Dollar Index	103.842	-0.094	-0.09%

Crude Oil WTI	69.11	0.00	0.00%
Brent Oil	72.49	+0.12	+0.17%
Natural Gas	3.891	-0.063	-1.59%
Gold	3,053.46	+9.46	+0.31%
Silver	34.178	+0.727	+2.17%
US Soybeans	1,002.25	-5.00	-0.50%
Copper	5.2180	+0.1255	+2.46%

Philippines 2Y	5.680	-0.050	-0.87%
Philippines 10Y	6.220	+0.010	+0.16%
Philippines 20Y	6.430	+0.070	+1.10%
U.S. 2Y	4.007	-0.030	-0.74%
U.S. 10Y	4.307	-0.024	-0.55%
U.S. 30Y	4.653	-0.003	-0.06%
Germany 10Y	2.7945	+0.0005	+0.02%

Alphabet C	172.47	+2.54	+1.49%
Golden Haven	2,300.00	-100.00	-4.17%
Anheuser Busch ADR	61.73	+0.20	+0.32%
Booking	4,776.15	+66.43	+1.41%
Apple	223.49	+2.76	+1.25%
Alibaba ADR	132.55	-1.93	-1.44%
Tesla	284.70	+6.31	+2.27%

Recent Quotes

	Name	Price	Chg.	Chg. %
	ARGX	601.82	-6.14	-1.01%

Market Movers

Name	Last	Chg. %	Vol.
Ayala Land	22.250	0.00%	8.70M
DigiPlus Interactive	35.050	-4.10%	6.05M
BDO Unibank	156.00	-0.89%	3.56M
Metropolitan Bank	73.00	-0.82%	3.03M
Jollibee Foods	232.80	-3.00%	1.39M
International Container	363.200	+0.89%	1.31M
Manila Electric	525.00	+0.38%	370.62K

Name	Last	Chg. %	Vol.
NiHAO Mineral	0.335	+24.07%	20.00K
Cirtek Holdings Philippines Prf	11.00	+15.79%	1.80K
Grand Plaza Hotel	5.980	+14.56%	0.50K
Lodestar Investment	0.2430	+10.45%	10.00K
Alliance Foods	0.500	+8.70%	190.00K
Philippine Infradev	0.280	+7.69%	80.00K
ArthaLand Prf s	482.80	+7.29%	10.00

Name	Last	Chg. %	Vol.
United Paragon Mining	0.0031	-18.42%	56.00M
Kepwealth Property	1.31	-15.48%	1.00K
Philippine Realty	0.121	-12.95%	20.00K
Metro Alliance Holdings Equities	0.63	-8.70%	6.00K
Cityland Development	0.600	-7.69%	36.00K
Oriental Petrol B	0.0074	-7.50%	5.00M
Oriental Peninsula	0.4350	-7.45%	20.00K